![](/image/Cepheid+Default+banner.jpeg)
News Releases
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jul 28, 2016
-
Jul 12, 2016Xpert HPV Fulfills International Requirements for Use as Primary Screening Test
-
Jul 5, 2016Hammersmith Broadway is Next in a Series of Clinics to Offer Fast and Discrete Testing.
-
Jun 30, 2016Xpert Carba-R Test is the First FDA-Cleared Molecular Test for Rapid Detection of Carbapenemase Producing Organisms Directly from Rectal Swab Specimens
-
Jun 15, 2016Broadens Access to Critical Diagnostic Results for Infants Born with HIV
-
Apr 28, 2016
-
Apr 21, 2016Further Broadens Reach of GeneXpert System into Non-Acute Market in United States
-
Apr 11, 2016Cepheid Highlights Role of Diagnostics as Valuable Tool in Growing Fight Against Antibiotic Resistance
-
Mar 29, 2016The Number One, On-Demand Molecular Test for MRSA Colonization is Now Improved
-
Mar 9, 2016Xpert Carba-R Results in Less Than an Hour Help to Prevent and Manage Outbreaks
-
Mar 7, 2016Dean Street Express Expanding to Additional Locations using GeneXpert Infinity System
-
Feb 2, 2016Commercial Clinical Grew 19%, or 21% in Constant Currency, Driven by Record Reagent Revenue and Record GeneXpert System Placements
-
Jan 13, 2016GeneXpert Systems and Xpert Tests Expected to Enhance Efficiency of Clinical Trials
-
Jan 11, 2016Announces Preliminary Q415 Revenue of Approximately $147 Million
-
Dec 8, 2015Xpert BCR-ABL Ultra Assesses Deep Molecular Response in Chronic Myeloid Leukemia Patients on Treatment with Tyrosine Kinase Inhibitors